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dense subchondral bone may render cartilage more susceptible 
to compressive injury. Biomarkers of bone turnover are normal 
in the obese, but increase with even minor weight loss. Dyslipi- 
demia and hyperuricemia ssociated with obesity do not impact 
OA, but adipocyte synthesized hormones (leptin, adiponectin and 
resistin), cytokines (IL-1, 11-6 and TNF-~) and C-reactive protein 
warrant further research. BMI is a risk factor for progression of 
joint space narrowing, but the impact of obesity on progression 
of medial compartment kOA (mckOA) is largely explained by the 
presence of mild to moderate varus malalignment. Gait biome- 
chanics are impacted by pain, kOA and BMI. Maximum joint re- 
action forces (JRF) are 3-5 times body weight. Knee adduction 
moment (KAM),the largest contributor to the knee JRF, moves the 
knee in a varus direction throughout most of stance phase. Base- 
line high KAMs are associated with rapid progression of mckOA. 
Biomechanical studies in painful kOA have demonstrated e- 
creased knee range of motion in swing and stance phase, de- 
creased velocity, and stride length and increased KAM. Lower 
walking rates and stride lengths reduce the KAM, perhaps de- 
creasing pain in kOA. 
Eliminating knee pain normalizes the velocity and stride length 
and improves range of motion. Ankle and hip ROM and JRFs 
impact on knee JRFs but are less well studied. Obese subjects 
without knee pain also have slower velocity, shortened stride, 
widened stance, prolonged stance phase and larger ground reac- 
tion forces. The obese gait is more erect, with less hip flexion and 
less knee ROM. Ankle plantar flexion (ROM and forces at push- 
off) vary with the presence of knee pain. This may be an effort 
to redistribute knee JRFs or inability to generate sufficient forces 
during the gait cycle because of excess weight. In our studies, 
obese subjects who lost 100 pounds over 12-18 months following 
gastric bypass surgery experienced improvements in pain, func- 
tion and knee ROM during stance and swing phase, but the KAM 
and other kinetic parameters, which had been abnormal relative 
to normal weight controls, did not improve with weight loss. 
Understanding the effect of obesity on kOA will help with both 
symptomatic patient management and disease modification. 
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ADIPOKINES AND OSTEOARTHRITIS 
P Pottie 
OA is considered as a disease of the whole joint that may re- 
sult from multiple pathological mechanisms, one of which may be 
the dysregulation of lipid homeostasis. Adipokines are hormones 
synthesized by adipocytes that signal changes in the mass of adi- 
pose tissue and energy status to other organs that control fuel us- 
age. Many arguments showed that adipokines are implicated in 
the mechanism of degenerative breakdown of cartilage and also 
osteophytes formation; leptin and its receptors have been identi- 
fied in human cartilage and display stimulatory effects on proteo- 
glycan synthesis in rats; location and the extent of leptin expres- 
sion were related to the degree of cartilage damage and paral- 
leled the expression of the growth factors IGF 1 -and TGF-I~; intra- 
articular injection of leptin into rat knee joints induced the synthe- 
sis of IGF1 and TGF-I~ in cartilage at both the messenger RNA 
and protein levels, and strongly stimulated the anabolic function 
of chondrocytes. Leptin levels in synovial fluid of patients with OA 
are higher than serum levels and are correlated with BMI. There 
is a gender disparity toward patients (leptin level in female > lep- 
tin levels in male) suggesting that leptin could explain the higher 
prevalence of OA in women. Furthermore, other adipokines uch 
as adiponectin and resistin were also found in synovial fluid of 
patients with OA at lower levels compared to serum. 
So OA seems to involve adipose factors such as leptin, resistin 
and adiponectin which may influence cartilage metabolism. Fur- 
ther works are required to determine the influence of adipokines 
on articular tissues and, if its presence in arthritic joint is cause 
or effect of OA. 
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GROWTH FACTOR NETWORKS IN OSTEOARTHRITIS 
Anneliese D Recklies 
The development and maintenance of articular cartilage and its 
repair following traumatic or degenerative injury are often thought 
of mechanistically as similar processes, with establishment of a 
functional matrix as the final objective. In addition to the well- 
studied IGF-1 and TGF-I~ growth factor families new families of 
growth factors which may regulate cartilage homeostasis have 
been described more recently, amongst them the connective tis- 
sue growth factor family and members of the chitinase 3-like pro- 
tein family. The chitinase 3-like proteins are unique in that they 
apparently do not play a major role in growth and development 
of articular cartilage, but are abundantly expressed in injured or 
degenerate tissue. The mechanisms by which they affect connec- 
tive tissue turnover will be reviewed. In addition these proteins are 
expressed in many organs during the processes leading to tissue 
fibrosis, which involves the excessive growth of connective tis- 
sue cells and deposition of extracellular matrix. Both TGF-I~ and 
connective tissue growth factors have been implicated in these 
processes. Adult articular chondrocytes, particularly in the super- 
ficial region, display a number of features and response pattern 
suggestive of a fibrotic response. The case will be made that fi- 
brotic reactions could be part of the response repertoire of adult 
articular chondrocytes to tissue injury. 
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GENE THERAPY APPROACHES TO CARTILAGE REPAIR 
CH Evans 
Gene transfer promises to enhance the reparative activities of 
cells involved in the healing of focal cartilage lesions. Among the 
advantages of this approach is the unique ability to express spe- 
cific gene products locally within the defect for an extended period 
of time. Traditional gene therapy strategies include the ex viva ex- 
pansion and genetic modification of autologous chondrocytes or 
chondroprogenitor cells that are subsequently seeded onto scaf- 
folds and implanted into the lesion. Although biologically promis- 
ing, such technologies are unlikely to be cost-effective and con- 
venient in clinical practice. As an alternative, we are developing 
expedited approaches that do not require multiple ex viva cultur- 
ing steps or artificial scaffolds, and can be accomplished in a sin- 
gle operative procedure. To this end, autologous bone marrow is 
being investigated as a convenient source of chondroprogenitor 
cells that can be genetically modified and, following coagulation, 
press-fit into cartilage lesions during a single procedure. 
We have found that bone marrow aspirates obtained from the il- 
iac crests of rabbits can be reproducibly clotted following genetic 
modification with adenoviral vectors and mediate transgene ex- 
pression for at least 2 weeks when cultured in situ. Moreover, 
after the transfer of suitable chondrogenic DNAs, bone marrow 
clots undergo chondrogenesis in culture without he need for en- 
dogenous chondrogenic factors. Based upon these observations, 
we have developed an intra-operative surgical procedure in which 
marrow is retrieved from the rabbit and combined with suspen- 
sions of recombinant adenovirus while coagulation occurs. The 
genetically modified coagulum ("gene plug") is then press-fit into 
the cartilage lesion where transgene expression persists. Pre- 
liminary data suggest that chondrogenesis occurs within the im- 
planted material, leading to the formation of cartilaginous repair 
tissue. Once optimized, this type of procedure promises to pro- 
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vide the orthopaedic surgeon with a simple, inexpensive, cost- 
effective, novel modality for the repair of cartilage lesions. 
Reference 
[1] Pascher et al. Gene transfer to cartilage defects using co- 
agulated bone marrow aspirate. Gene Therapy 11: 133-141, 
2004. 
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STEM CELLS AND SKELETAL TISSUE REGENERATION 
Brian Johnstone 
Adult stem or progenitor cells have now been detected in most tis- 
sues of the body, including those relevant o the musculoskeletal 
system - trabecular bone, bone marrow, periosteum, cartilages, 
synovium, adipose and muscle. The cells of most tissues have 
been shown to have chondrogenic, osteogenic and adipogenic 
differentiation potential, and within bone marrow and muscle, cer- 
tain subfractions with greater differentiation potential are now de- 
scribed. Despite these advances, the relationship between the 
various cells of the different issues is unclear, as is their rela- 
tive importance in the field of regenerative medicine. Stem cell- 
based therapies are still a goal of many in the skeletal biology 
field. However, the early promise has been tempered by the real- 
ization of the complexity of stem cell interactions within implants 
and host tissues that must be understood if we are to provide 
effective regenerative tissues for skeletal pathologies. These is- 
sues will be discussed with examples from our work with human 
tissue-derived cells in attempts to define them and translate the 
findings into cell-based therapies. 
20 
PROTEOMICS IN OSTEOARTHRITIS 
Jeremy Saklatvala 
Proteomics is the study of the total complement of proteins of an 
organism. Generally, proteins of a cell or tissue extract are sepa- 
rated by 2-dimensional gel electrophoresis, detected by sensitive 
staining, excised and identified by mass spectrometry. 
The technique is complementary to transcriptomic analysis. It 
shows the actual level of expression of proteins, and their post- 
translational modifications (i.e. are they appropriately processed, 
glycosylated, phosphorylated and so on). Its limitations are that 
a) it is not possible to resolve the thousands of proteins in a cell by 
current separation methods, b) abundant proteins hinder detec- 
tion of less abundant, c) certain types of protein e.g. membrane 
proteins, very large proteins and those with extreme isoelectric 
points are often not resolved by current gel separation methods, 
and d) quantification is difficult. 
If the aim is to analyse differences between samples, for instance 
between diseased and normal material, or between cells under- 
going different reatments, samples can either be run side by side, 
or various approaches are used in which the two samples are 
mixed and then separated together, after treating them with dif- 
ferent protein dyes, or after differential isotopic labelling. 
We have developed proteomic analysis of articular cartilage, 
firstly, to find out what regulatory molecules it makes, and sec- 
ondly to compare normal with osteoarthritic tissue. Because of 
the impossibility of resolving all the cellular proteins we concen- 
trated on analysing those secreted by chondrocytes in tissue ex- 
plants ex-vivo, and we labelled these metabolically in culture with 
35S-containing methionine and cysteine to be sure we were de- 
tecting chondrocyte proteins. Articular cartilage contains plasma 
proteins and cellular debris such as haemoglobin, which have to 
be washed out of the tissue. If this is not done, analysis of the la- 
belled proteins, which have to be visualisable as silver-stainable 
spots, is prevented. A major technical hurdle was that the proteo- 
glycans, particularly aggrecan, prevented iso-electric focussing 
of other cartilage proteins and had to be removed selectively; this 
was achieved with the cationic detergent cetylpyridirium chloride. 
We were able to produce good maps of the chondrocyte 'secre- 
tome', resolving one to two hundred protein spots and identifying 
forty or so newly synthesised proteins. Differences, particularly 
in collagen II secretion and processing were seen between nor- 
mal and osteoarthritic tissue, and between cartilage of different 
ages. The maps also revealed two potentially important regula- 
tory molecules, activin A and connective tissue growth factor. Ac- 
tivin A was made in striking amounts and its existence in articu- 
lar cartilage has not been previously recognised. Further experi- 
ments suggest it may have important functions regulating matrix 
catabolism in cartilage. 
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EVALUATING SUBCHONDRAL BONE IN 
OSTEOARTHRITIS 
Sharmila Majumdar 
In addition to changes in cartilage that occur in OA, it is sug- 
gested that early changes are seen in the adjoining subchondral 
and trabecular bone. Articular cartilage and subchondral bone 
act in concert with regards to the mechanical oading of the joint 
and its disruption due to injury. The subchondral mineralized zone 
is recognized to play an important role in reducing the axial im- 
pact forces typically encountered uring dynamic joint loading [1] 
and adapts to the mechanical demands during normal and abnor- 
mal joint loading [2-4]. Numerous investigators have measured 
radiographic density of the subchondral bone [2-4]; Eckstein et 
al. have shown that distribution of thickness of subchondral bone 
in the patella show differences between males and females and 
relate to the occurrence of cartilage lesions in the medial com- 
partments, but not in the lateral compartments [5]. In a guinea 
pig menisectomy model, an initial loss of trabecular bone vol- 
ume and thickness was evident, while in the advanced stages, 
there was an enhancement of trabecular volume and thickness 
[6] as demonstrated by micro-CT. In an anterior cruciate liga- 
ment transection induced canine OA model, even after fifty-four 
months of OA, the increase in subchondral bone thickness was 
accompanied by a loss of trabecular bone and thinning [7], also 
demonstrated by micro-CT. Recent advances have made it pos- 
sible to use MR to assess bony changes in addition to soft tissue 
changes. Assessment of bony changes in OA was investigated in 
a guinea pig model [8], and investigators found that the signal in- 
tensity of trabecular bone in MR images accurately reflected the 
degree of osteopenia and trabecular thinning noted around the 
cruciate ligament insertions. The extent of subchondral sclerosis 
and the development of marginal osteophytes were also accu- 
rately represented. Serial observations revealed that MRI can de- 
tect highly significant progression of lytic bone lesions, subchon- 
dral sclerosis, and osteophyte size over periods of six weeks. A 
more recent development in the assessment of trabecular bone 
structure is the use of MRI techniques to obtain non-invasive 
bone biopsies at multiple anatomic sites, quantify trabecular ar- 
chitecture, and derive measures such as the trabecular width, tra- 
becular bone fraction, mean intercept length as well as quantita- 
tive measures of texture such as the fractal characteristics of the 
trabecular bone network [9-12]. Using these techniques, Beuf et 
al. have shown differences between the femoral and tibial bone 
structure in osteoarthritic knees [13], while Lindsey et al. have 
found a relationship between bone structure and articular carti- 
lage morphology in subjects with OA [14]. Blumenkrantz et al. [15] 
have examined bone and cartilage changes longitudinally. They 
